Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

about

Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.

P2860

Q39297100-FCF593EB-D12B-45AF-99B2-EEE5B9CD1D40

P2860

Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

Item

http://www.wikidata.org/entity/Q38766966

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pathological and clinical aspe ...... disease and related disorders.

@en

type

Item

label

Pathological and clinical aspe ...... disease and related disorders.

@en

prefLabel

Pathological and clinical aspe ...... disease and related disorders.

@en

P1476

Pathological and clinical aspe ...... disease and related disorders.

@en

P2093

Michael Tolmasov

http://www.w3.org/2001/XMLSchema#string

Nirit Lev

http://www.w3.org/2001/XMLSchema#string

Ruth Djaldetti

http://www.w3.org/2001/XMLSchema#string

Yossi Gilgun-Sherki

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic organization and expression of the human beta-synuclein gene (SNCB)

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies

αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction

P304

505-513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.2016.1164600

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26959397

http://www.w3.org/2001/XMLSchema#string

P921

Synuclein

Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

about

P2860

P2860

Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921